Breast Cancer Screening Market is projected US$ 21 Billion by 2024

Access full Research:
https://www.renub.com/breast-cancer-screening-mammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php

Get Free Customization in This Report

Breast Cancer Screening Market is projected to reach US$ 21 Billion by the end of year 2024. In both the developed and developing countries, Breast Cancer is the top cancer among women. The incidence of breast cancer is rising in the lower income countries due to increase in life expectancy, adaption of western lifestyles and increasing urbanization. Globally, more than half of the breast cancer cases now have been reported from low and middle income countries (LMICs) as these countries do not have proper breast screening programmes, hence, the majority of cases diagnosed in late stages.

To reverse the trend of increasing breast cancer incidences & mortality in the low and middle income countries, these countries need to develop an effective strategy which not only will carry a broad breast cancer screening programs but will also address the growing incidence of breast cancer and disease-related deaths. Such strategy may include public and medical community awareness, and partnerships between community advocates, governments, non-governmental organizations & biotechnology.

Request a free sample copy of the report: https://www.renub.com/contactus.php

Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway, Switzerland, India, China, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand)” provides a detailed and comprehensive insight of the Breast Cancer Screening Market.

By Screening Tests - Mammography is the Most Common Test for Breast Cancer Screening
Mammography is a specialized medical imaging, which uses a low-dose x-ray system to see inside the human breasts. Mammography plays a central part in the early detection and diagnosis of breast diseases in women. Apart from mammography, breast Magnetic Resonance Imaging (MRI) or breast ultrasound, also helps detection of breast cancer in women.

By Countries – United States, China, Germany, United Kingdom together hold considerable market share
United States, China, Germany and United Kingdom tend to have the considerable share in the Breast Cancer Screening Market. In addition; the report also provides the complete analysis of Canada, France, Italy, Spain, Netherlands, Norway, Switzerland, India, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, Australia and New Zealand Breast Cancer Screening Market & Population.

The report provides a complete analysis of the key Growth Drivers and Challenges, Market, Screened Population and their projections for the upcoming years (2024).

Breast Cancer Screening Market - By Screening Tests Covered in the Report:
• Mammography
• Magnetic Resonance Imaging (MRI)
• Ultrasound

Regions Covered in the Report:
1. United States
2. Canada
3. United Kingdom
4. France
5. Germany
6. Italy
7. Spain
8. Netherlands
9. Norway
10. Switzerland
11. India
12. China
13. Japan
14. Korea
15. Singapore
16. Thailand
17. Malaysia
18. Brazil
19. Australia
20. New Zealand

Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.